论文部分内容阅读
关于开始或者持续用药提供患者用药信息,对决策的影响是未知的。本研究的目的是为了评价对开始或继续提供药品的决策的影响,提供相应的药品信息可能会给患者带来的利益和/或危害。研究数据来源是从1980年至2010年10月,对纳入研究的参考和引用进行电子搜索。研究选择两名调查研究人员对纳入标准的资格进行评审:进行随机或伪随机试验;参与者年龄超过16岁,并通过自己意愿决定参加;一组接受可能带来的有益和/
The impact on decision making about starting medication or continuing medication with patient medication is unknown. The purpose of this study is to evaluate the impact on the decision to start or continue to provide the drug and to provide the benefit and / or the hazard that the corresponding drug information may bring to the patient. The source of the research data is from 1980 to October 2010, electronic search of references and references for inclusion in the study. The study selected two investigators to review eligibility for inclusion criteria: randomized or pseudo-randomized trials; participants over 16 years of age and decided to participate as they intended; and a group that accepted probable benefit and /